Skip to content

Clinical trials

Observational Bile Duct Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bile Duct Neoplasms Phase: Observational Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20041
20051
20071
20082
20091
20113
20121
20133
20141
20162
20172
20181
20193
20206
20213
20221
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status13
Recruiting7
Active, not recruiting2
Terminated2
Withdrawn2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center3
Weill Medical College of Cornell University3
Mayo Clinic2
Air Force Military Medical University, China1
Asian Institute of Gastroenterology, India1
CHANGHEE LEE1
Central Hospital, Nancy, France1
Centro di Riferimento Oncologico - Aviano1
Fujian Provincial Hospital1
George Zogopoulos1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bile Duct Neoplasms42
Pancreatic Neoplasms28
Cholangiocarcinoma15
Stomach Neoplasms14
Esophageal Neoplasms11
Colonic Neoplasms10
Gallbladder Neoplasms10
Liver Neoplasms10
Rectal Neoplasms9
Carcinoma, Hepatocellular8

Trials

Showing 51 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.